Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy

Cornelius D. Jamison, Jenell S. Coleman Fennell, Okeoma Mmeje

Research output: Contribution to journalArticle

Abstract

Sexually transmitted infections (STI), including Chlamydia trachomatis and Neisseria gonorrhoeae, have reached record high rates in the United States. Sexually transmitted infections disproportionately affect reproductive-aged females aged 15-44 years, who account for 65% and 42% of the total reported C trachomatis and N gonorrhoeae cases, respectively. Undiagnosed STIs can result in serious health complications that put women at an increased risk for pelvic inflammatory disease, ectopic pregnancy, and tubal factor infertility. Many of these women are seen by physicians (eg, obstetrician-gynecologists, family medicine doctors, pediatricians) or other clinicians (eg, nurse practitioners, midwives, physician assistants) who care for women. These clinicians have the opportunity to help curb the continued increase in STI incidence rates with the implementation and use of expedited partner therapy. Expedited partner therapy is a proven effective health care practice that allows clinicians to give patients medications or prescriptions to distribute to their partners. Despite expedited partner therapy's proven effectiveness, there are barriers to its implementation that must be understood to enhance STI treatment and prevention efforts. In this commentary, we discuss these barriers, and appeal to women's health clinicians to implement or increase use of expedited partner therapy for the treatment of women with STIs and their sexual partners.

Original languageEnglish (US)
Pages (from-to)416-422
Number of pages7
JournalObstetrics and gynecology
Volume133
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Women's Health
Sexually Transmitted Diseases
Therapeutics
Women Physicians
Nurse Midwives
Physician Assistants
Pelvic Inflammatory Disease
Nurse Practitioners
Neisseria gonorrhoeae
Gonorrhea
Ectopic Pregnancy
Sexual Partners
Chlamydia trachomatis
Infertility
Prescriptions
Medicine
Delivery of Health Care
Incidence
Health

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy. / Jamison, Cornelius D.; Coleman Fennell, Jenell S.; Mmeje, Okeoma.

In: Obstetrics and gynecology, Vol. 133, No. 3, 01.03.2019, p. 416-422.

Research output: Contribution to journalArticle

@article{f4305f6fa38146788d6fa2c324a6a7e3,
title = "Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy",
abstract = "Sexually transmitted infections (STI), including Chlamydia trachomatis and Neisseria gonorrhoeae, have reached record high rates in the United States. Sexually transmitted infections disproportionately affect reproductive-aged females aged 15-44 years, who account for 65{\%} and 42{\%} of the total reported C trachomatis and N gonorrhoeae cases, respectively. Undiagnosed STIs can result in serious health complications that put women at an increased risk for pelvic inflammatory disease, ectopic pregnancy, and tubal factor infertility. Many of these women are seen by physicians (eg, obstetrician-gynecologists, family medicine doctors, pediatricians) or other clinicians (eg, nurse practitioners, midwives, physician assistants) who care for women. These clinicians have the opportunity to help curb the continued increase in STI incidence rates with the implementation and use of expedited partner therapy. Expedited partner therapy is a proven effective health care practice that allows clinicians to give patients medications or prescriptions to distribute to their partners. Despite expedited partner therapy's proven effectiveness, there are barriers to its implementation that must be understood to enhance STI treatment and prevention efforts. In this commentary, we discuss these barriers, and appeal to women's health clinicians to implement or increase use of expedited partner therapy for the treatment of women with STIs and their sexual partners.",
author = "Jamison, {Cornelius D.} and {Coleman Fennell}, {Jenell S.} and Okeoma Mmeje",
year = "2019",
month = "3",
day = "1",
doi = "10.1097/AOG.0000000000003088",
language = "English (US)",
volume = "133",
pages = "416--422",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Improving Women's Health and Combatting Sexually Transmitted Infections Through Expedited Partner Therapy

AU - Jamison, Cornelius D.

AU - Coleman Fennell, Jenell S.

AU - Mmeje, Okeoma

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Sexually transmitted infections (STI), including Chlamydia trachomatis and Neisseria gonorrhoeae, have reached record high rates in the United States. Sexually transmitted infections disproportionately affect reproductive-aged females aged 15-44 years, who account for 65% and 42% of the total reported C trachomatis and N gonorrhoeae cases, respectively. Undiagnosed STIs can result in serious health complications that put women at an increased risk for pelvic inflammatory disease, ectopic pregnancy, and tubal factor infertility. Many of these women are seen by physicians (eg, obstetrician-gynecologists, family medicine doctors, pediatricians) or other clinicians (eg, nurse practitioners, midwives, physician assistants) who care for women. These clinicians have the opportunity to help curb the continued increase in STI incidence rates with the implementation and use of expedited partner therapy. Expedited partner therapy is a proven effective health care practice that allows clinicians to give patients medications or prescriptions to distribute to their partners. Despite expedited partner therapy's proven effectiveness, there are barriers to its implementation that must be understood to enhance STI treatment and prevention efforts. In this commentary, we discuss these barriers, and appeal to women's health clinicians to implement or increase use of expedited partner therapy for the treatment of women with STIs and their sexual partners.

AB - Sexually transmitted infections (STI), including Chlamydia trachomatis and Neisseria gonorrhoeae, have reached record high rates in the United States. Sexually transmitted infections disproportionately affect reproductive-aged females aged 15-44 years, who account for 65% and 42% of the total reported C trachomatis and N gonorrhoeae cases, respectively. Undiagnosed STIs can result in serious health complications that put women at an increased risk for pelvic inflammatory disease, ectopic pregnancy, and tubal factor infertility. Many of these women are seen by physicians (eg, obstetrician-gynecologists, family medicine doctors, pediatricians) or other clinicians (eg, nurse practitioners, midwives, physician assistants) who care for women. These clinicians have the opportunity to help curb the continued increase in STI incidence rates with the implementation and use of expedited partner therapy. Expedited partner therapy is a proven effective health care practice that allows clinicians to give patients medications or prescriptions to distribute to their partners. Despite expedited partner therapy's proven effectiveness, there are barriers to its implementation that must be understood to enhance STI treatment and prevention efforts. In this commentary, we discuss these barriers, and appeal to women's health clinicians to implement or increase use of expedited partner therapy for the treatment of women with STIs and their sexual partners.

UR - http://www.scopus.com/inward/record.url?scp=85062082266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062082266&partnerID=8YFLogxK

U2 - 10.1097/AOG.0000000000003088

DO - 10.1097/AOG.0000000000003088

M3 - Article

VL - 133

SP - 416

EP - 422

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -